Aterian (NASDAQ:ATER) Issues Earnings Results

Aterian (NASDAQ:ATERGet Free Report) announced its earnings results on Saturday. The company reported ($0.97) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.58) by ($0.39), FiscalAI reports. The company had revenue of $15.13 million for the quarter, compared to analysts’ expectations of $18.38 million. Aterian had a negative net margin of 15.73% and a negative return on equity of 47.45%.

Aterian Trading Up 1.7%

ATER opened at $0.60 on Monday. Aterian has a 1-year low of $0.52 and a 1-year high of $2.56. The company has a market capitalization of $6.02 million, a PE ratio of -0.37 and a beta of 0.02. The firm’s 50 day simple moving average is $0.65 and its two-hundred day simple moving average is $0.80.

Hedge Funds Weigh In On Aterian

A number of institutional investors have recently bought and sold shares of the stock. XTX Topco Ltd bought a new stake in Aterian during the second quarter valued at about $55,000. Susquehanna International Group LLP grew its stake in shares of Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after acquiring an additional 30,637 shares during the period. Citadel Advisors LLC increased its holdings in Aterian by 222.0% in the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after acquiring an additional 22,865 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in Aterian by 73.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock worth $45,000 after acquiring an additional 9,026 shares during the period. 7.02% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aterian in a report on Wednesday, January 21st. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce”.

Read Our Latest Analysis on Aterian

About Aterian

(Get Free Report)

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.

Further Reading

Earnings History for Aterian (NASDAQ:ATER)

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.